SFM
PTLA

Sphera Funds Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Sphera Funds Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200,000
Closed -$6.53M – 139
2018
Q1 		$6.53M Buy
+200,000
New +$8.78M 0.99% 27
2016
Q2 		– Sell
-80,100
Closed -$1.63M – 118
2016
Q1 		$1.63M Buy
+80,100
New +$2.54M 0.35% 63

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Sphera Funds Management's PTLA Position: Q1 2020 in Review

Sphera Funds Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 317,000 shares — an estimated $7.57M sold.

Sphera Funds Management first reported a position in PTLA in Q4 2013 and held it in 16 quarters. The position peaked at $10.2M in Q4 2017. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Sphera Funds Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Sphera Funds Management sold 317,000 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $7.57M.
  • Sphera Funds Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 16 quarters.
  • Sphera Funds Management's Portola Pharmaceuticals, Inc. position peaked at $10.2M in Q4 2017.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Sphera Funds Management's 13F filing for Q1 2020, filed 14 May 2020.